Is Obama’s appointment of “health policy Czar” to progressive Nancy-Ann DeParle’s another case of an industry insider who would never have survived congressional scutiny and confirmation? Of course it is. Even our disfuntional and corrupt Congress would have to deny her a conformation. Does she have a very comprehensive understanding of the ins and outs of America’s health care system. Of course she does. I would say she knows it too well. She’s managed to make millions of dollars from the industry in the way of stock options and salaries from companies she has sat on the Boards of. She’s part of Washington’s revolving door which allows federal employees to leave the government and hook up with the companies they were overseeing, and then come back to work for the federal government and oversee the companies they were working for, ad infinum. There is so much wrong with DeParle and her conflicts of interest (quite a few), I would expect great future success of her former employers’ relationship with the federal government.
First, here are several appropriate statements and quote provided by the Investigative Reporting Workshop at American University School of Communication:
And the public wasn’t told that much of that corporate career was built at companies that have frequently had to defend themselves against federal investigations. After leaving government, DeParle accepted director positions at half a dozen companies suspected of violating the very laws and regulations she had enforced for Medicare. Those companies got into further trouble on her watch as a director.
“This woman owes her fortune to the corporations that she is making decisions about,” said Dr. David Himmelstein, an associate professor of medicine at Harvard University and a co-founder of Physicians for a National Health Program. “She cashed in really big on her previous role in government and made millions and millions of dollars. Then she divests and all of a sudden she’s Snow White. It’s ridiculous.”
At three companies — Guidant, DaVita and Specialty Laboratories — DeParle was not only a director but also served on board committees responsible for monitoring the companies’ compliance with laws and regulations.
Federal Government Experience
1993-97, Associate Director for Health and Personnel at the White House Office of Management and Budget
1997-2000, Administrator of the Health Care Financing Administration (HCFA), recently renamed the Centers for Medicare and Medicaid Services (CMS). As headed up Medicare, Medicaid, and SCHIP. Additional information
2002-2008, Medicare Payment Advisory Commission (MEDPAC).
The Medicare Payment Advisory Commission (MedPAC) is an independent Congressional agency established by the Balanced Budget Act of 1997 (P.L. 105-33) to advise the U.S. Congress on issues affecting the Medicare program. They discuss policy issues and formulate its recommendations to the Congress.
JP Morgan Chase – no explanation needed
CCMP Capital Advisors – expertise in healthcare infrastructure
Accredo Health, Inc, acquired by Medco Health Solutions – provides specialized pharmacy (mail service) and related services
Triad Hospitals – ownes 115 hospitals in the U.S. Purchased by JP Morgan CCMP Capital Advisors and Goldman Sachs in 2007
Cerner – major mfg of electronic medical records software
Legacy Hospital Partners – owned by JP Morgan’s CCMP Capital Partners, privately held company established to provide essential capital and expertise to not-for-profit hospitals and hospital systems and forms joint ventures to acquire, own, operate and manage acute care facilities
Caremore Health Plan – provide focused and innovative healthcare approaches to the complex problems of aging and protect precious financial resources of seniors and the Medicare Program through innovative methods of managing chronic disease, frailty, and end of life
DaVita Corp – provider of dialysis services
Boston Scientific, Inc – develops innovative products, technologies and services across a wide range of medical specialties
To be continued